IRIS
SCIONTI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 850
EU - Europa 672
AS - Asia 494
SA - Sud America 44
AF - Africa 26
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.096
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 805
IT - Italia 333
SG - Singapore 272
GB - Regno Unito 76
DE - Germania 74
FI - Finlandia 49
IN - India 49
CN - Cina 43
BR - Brasile 34
SE - Svezia 33
CA - Canada 32
NL - Olanda 25
JO - Giordania 21
HK - Hong Kong 19
PK - Pakistan 19
ID - Indonesia 16
ES - Italia 13
FR - Francia 12
RU - Federazione Russa 11
CZ - Repubblica Ceca 10
ZA - Sudafrica 10
SA - Arabia Saudita 9
LT - Lituania 8
MX - Messico 8
EG - Egitto 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
BD - Bangladesh 5
IE - Irlanda 5
IQ - Iraq 5
IR - Iran 5
CY - Cipro 4
RO - Romania 4
BG - Bulgaria 3
EC - Ecuador 3
ET - Etiopia 3
LB - Libano 3
NG - Nigeria 3
PE - Perù 3
PH - Filippine 3
TR - Turchia 3
AT - Austria 2
CO - Colombia 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JP - Giappone 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
MY - Malesia 2
PS - Palestinian Territory 2
UA - Ucraina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
NZ - Nuova Zelanda 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VN - Vietnam 1
Totale 2.096
Salva come PNG Salva come JPEG
Città #
Singapore 184
Chandler 161
Santa Clara 60
Chicago 55
Munich 52
London 45
Ashburn 44
Milan 36
Lawrence 34
Princeton 34
Turku 33
Catanzaro 27
Ottawa 19
Boardman 16
Helsinki 16
Los Angeles 16
Wilmington 15
Amman 13
Carbonia 12
San Nicola Manfredi 12
Rome 11
Spezzano della Sila 10
Hong Kong 9
Delhi 8
Irbid 8
Madrid 8
New York 8
Olomouc 8
Palermo 8
San Francisco 8
Brooklyn 7
Cosenza 7
Kaunas 7
Naples 7
The Dalles 7
Des Moines 6
Ercolano 6
Redmond 6
Afragola 5
Aversa 5
Cardiff 5
Chennai 5
Lucknow 5
Meppel 5
Riyadh 5
Sacramento 5
Santo Stefano di Rogliano 5
Seattle 5
São Paulo 5
Ahmedabad 4
Atlanta 4
Beijing 4
Brescia 4
Cape Town 4
Catania 4
Frankfurt am Main 4
Hyderabad 4
Jeddah 4
Lahore 4
Nicosia 4
Pune 4
Stockholm 4
Toronto 4
Acquaviva delle Fonti 3
Addis Ababa 3
Ajman 3
Andover 3
Banyumas 3
Berlin 3
Bologna 3
Bristol 3
Castrovillari 3
Decollatura 3
Dubai 3
Guangzhou 3
Hanover 3
Islamabad 3
Lima 3
Melbourne 3
Mileto 3
Mountain View 3
Noida 3
Oristano 3
Oxford 3
Paola 3
Parma 3
Quţūr 3
Redwood City 3
Richmond 3
San Antonio 3
Santo Tirso 3
Shanghai 3
Sofia 3
Waterford 3
6th of October City 2
Agrigento 2
Amsterdam 2
Asyut 2
Augusta 2
Bari 2
Totale 1.239
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 351
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 84
miR-22 suppresses DNA ligase III addiction in multiple myeloma 84
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 78
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 68
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis 59
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 54
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 53
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 50
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 47
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 47
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 45
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 44
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 40
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 39
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 39
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 39
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 38
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 37
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 37
Mmrf-commpass data integration and analysis for identifying prognostic markers 37
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 35
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 35
GENETIC SUSCEPTIBILITY TO GASTROINTESTINAL SYMPTOMS IN FABRY DISEASE 34
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 34
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 33
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 33
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 33
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 33
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 32
Integration of DNA Microarray with Clinical and Genomic Data 32
null 31
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 30
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 30
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 29
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 28
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine 28
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 27
Ethical Perspectives on Pharmacogenomic Profiling 23
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 23
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy. (IF 5.168) 22
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 22
Exploring the impact of lipid droplets on the evolution and progress of hepatocarcinoma 21
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 21
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 20
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 19
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 18
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 17
The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders 17
The potential role of miRNAs in multiple myeloma therapy 16
Advances in Alport syndrome diagnosis using next-generation sequencing 15
Functional Role of Linc-RNAs in Multiple Myeloma: Linc-MIR17HG Affects Fatty Acid Biosynthesis Via transcriptional Regulation of ACC1 with Potential Therapeutic Implications 15
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 14
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 10
The Effect of Physical Activity/Exercise on miRNA Expression and Function in Non-Communicable Diseases-A Systematic Review 10
High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndrome 8
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 5
Totale 2.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.830
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 8 1 2 6 5 6 6 7 9 12 1 0
2021/2022156 1 0 0 32 8 0 8 29 36 19 17 6
2022/2023453 75 31 22 19 59 40 7 33 60 33 49 25
2023/2024511 91 40 46 35 48 74 28 41 10 17 31 50
2024/2025976 92 33 33 50 62 126 73 60 56 23 156 212
2025/20265 5 0 0 0 0 0 0 0 0 0 0 0
Totale 2.223